2008
DOI: 10.3164/jcbn.2008033
|View full text |Cite
|
Sign up to set email alerts
|

Five-antituberculosis Drug-resistance Genes Detection Using Array System

Abstract: Summary Detection of resistance to drugs for Mycobacterium tuberculosis takes about two months from the sample collection using culture-based methods. To test a rapid method for detection of resistance for five antituberculosis drugs using DNA microarray and to examine its potential for clinical use, we employed a DNA microarray for detection of seven mutations genes related to resistance of five kinds of antituberculous drugs using Mycobacterium tuberculosis DNA isolated from sputum. The results of microarray… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
12
0
2

Year Published

2009
2009
2022
2022

Publication Types

Select...
5
1
1

Relationship

0
7

Authors

Journals

citations
Cited by 17 publications
(14 citation statements)
references
References 12 publications
0
12
0
2
Order By: Relevance
“…Microarray analysis of M. tuberculosis has facilitated a range of additional studies to provide important contributions on its mechanisms of drug resistance, host–pathogen interactions, in vitro and in vivo gene expression and functional analysis of particular genes . Previously, several in‐house or commercial arrays were designed for differentiating the M. tuberculosis complex from non‐tuberculous mycobacteria and for rapid detection of MDR and mono‐drug‐resistant M. tuberculosis as well as M. tuberculosis that is resistant to second‐line anti‐TB drugs . The TB‐Biochip oligonucleotide microarray system (Engelhardt Institute of Molecular Biology, Moscow, Russia), evaluated by Caoili et al .…”
Section: Introductionmentioning
confidence: 99%
“…Microarray analysis of M. tuberculosis has facilitated a range of additional studies to provide important contributions on its mechanisms of drug resistance, host–pathogen interactions, in vitro and in vivo gene expression and functional analysis of particular genes . Previously, several in‐house or commercial arrays were designed for differentiating the M. tuberculosis complex from non‐tuberculous mycobacteria and for rapid detection of MDR and mono‐drug‐resistant M. tuberculosis as well as M. tuberculosis that is resistant to second‐line anti‐TB drugs . The TB‐Biochip oligonucleotide microarray system (Engelhardt Institute of Molecular Biology, Moscow, Russia), evaluated by Caoili et al .…”
Section: Introductionmentioning
confidence: 99%
“…The report indicated a high sensitivity (90%) for all five drugs. 67 In this study specificities for RIF and EMB were nearly 90%, but the specificity for INH (60%) and kanamycin (67%) was not satisfactory. More recently, further attempts were started for rapid detection of resistance to fluoroquinolones by microarrays.…”
Section: Solid-phase Hybridization Assaysmentioning
confidence: 79%
“…There are a number of commercially available tests for M. tuberculosis available, and they are listed in Table 4.2. Shimizu et al [56] developed a DNA microarray that covered mutations in seven genes (inh, KatG, rpoB, rrs, rpsL, embB) which are responsible for antibiotic resistance against five anti-TB drugs (rifampicin, isoniazid, streptomycin, kanamycin, an ethambutol). The DNA microarray results were compared with standard culture-based sensitivity testing which took 2 months from sample collection.…”
Section: Mycobacteriamentioning
confidence: 99%
“…The HCII assay is based on hybridization in a solution with a mixture of nonisotopic, single-stranded, full-length RNA probes against 13 high-risk types (HPV 16,18,31,33,35,39,45,51,52,56,58,59,68). The assay detects several high-risk types in one reaction and uses a convenient format.…”
Section: Commercial Hpv Testsmentioning
confidence: 99%